What is the drug of choice for IgA nephropathy? Understanding the evolving treatment landscape
•
4 min read
As the most common form of primary glomerulonephritis worldwide, IgA nephropathy (IgAN) has no single cure, but its treatment is evolving rapidly. Addressing the question, 'what is the drug of choice for IgA nephropathy?' requires understanding that modern management involves a combination of foundational supportive care and newer targeted therapies tailored to the individual patient's risk profile.
